ICTHIOVAC VR/PD, EMULSION FOR INJECTION FOR SEA BASS
ICTHIOVAC VR/PD, EMULSION FOR INJECTION FOR SEA BASS
Authorised
- Photobacterium damselae, subsp. Piscicida, strain DI21, Inactivated
- Vibrio anguillarum, serotype O1, Inactivated
- Vibrio anguillarum, serotype O2b, Inactivated
- Vibrio anguillarum, serotype O2a, Inactivated
Product identification
Medicine name:
ICTHIOVAC VR/PD, EMULSION FOR INJECTION FOR SEA BASS
ICTHIOVAC VR/PD, emulzija za injekciju, za lubine
Active substance:
- Photobacterium damselae, subsp. Piscicida, strain DI21, Inactivated
- Vibrio anguillarum, serotype O1, Inactivated
- Vibrio anguillarum, serotype O2b, Inactivated
- Vibrio anguillarum, serotype O2a, Inactivated
Target species:
-
Seabass
Route of administration:
-
Intraperitoneal use
Product details
Active substance and strength:
-
Photobacterium damselae, subsp. Piscicida, strain DI21, Inactivated60.00Relative Percentage Survival1.00Dose
-
Vibrio anguillarum, serotype O1, Inactivated75.00Relative Percentage Survival1.00Dose
-
Vibrio anguillarum, serotype O2b, Inactivated75.00Relative Percentage Survival1.00Dose
-
Vibrio anguillarum, serotype O2a, Inactivated75.00Relative Percentage Survival1.00Dose
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intraperitoneal use
-
Seabass
-
Fish meat0degree day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI10X
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Package description:
- Available only in Croatian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/22-01/285
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0314/001
Concerned member states:
-
Croatia
-
Cyprus
-
Greece
-
Italy
-
Portugal
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Croatian (PDF)
Published on: 11/07/2022
How useful was this page?: